Human Placenta-Derived CD146-Positive Mesenchymal Stromal Cells Display a Distinct Osteogenic Differentiation Potential

Stem Cells and Development

Volumn 24, Issue 13, 2015, Pages 1558-1569

  Ulrich, Christine ^a   Abruzzese, Tanja ^a   Maerz, Jan K ^a   Ruh, Manuel ^a   Amend, Bastian ^a   Benz, Karin ^b   Rolauffs, Bernd ^a   Abele, Harald ^a   Hart, Melanie L ^a   Aicher, Wilhelm K ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD146 ANTIGEN; MEMBRANE ANTIGEN;

ADIPOGENESIS; ARTICLE; BONE DEVELOPMENT; BONE MARROW; CELL CULTURE; CELL DIFFERENTIATION; CELL EXPANSION; CELL ISOLATION; CELL LINEAGE; CELL POPULATION; CONTROLLED STUDY; CYTOCHEMISTRY; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MARKER GENE; MESENCHYMAL STROMA CELL; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; CYTOLOGY; FEMALE; GENETICS; METABOLISM; OSTEOBLAST; PREGNANCY;

ANTIGENS, CD146; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; HUMANS; MESENCHYMAL STROMAL CELLS; OSTEOBLASTS; OSTEOGENESIS; PLACENTA; PREGNANCY;

EID: 84931426703     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2014.0465     Document Type: Article

References (64)

1. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
2. Bianco P, X Cao, PS Frenette, JJ Mao, PG Robey, PJ Simmons and CY Wang. (2013). The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat Med 19:35-42.
3. Dominici M, K Le Blanc, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, D Prockop and E Horwitz. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317.
4. Sacchetti B, A Funari, S Michienzi, S Di Cesare, S Piersanti, I Saggio, E Tagliafico, S Ferrari, PG Robey, M Riminucci and P Bianco. (2007). Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131:324-336.
5. Parolini O, F Alviano, GP Bagnara, G Bilic, HJ Buhring, M Evangelista, S Hennerbichler, B Liu, M Magatti, et al. (2008). Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on placenta derived stem cells. Stem Cells 26:300-311.
6. Pilz GA, J Braun, C Ulrich, T Felka, K Warstat, M Ruh, B Schewe, H Abele, A Larbi and WK Aicher. (2011). Human mesenchymal stromal cells express CD14 cross-reactive epitopes. Cytometry A 79:635-645.
7. Tormin A, O Li, JC Brune, S Walsh, B Schüz, M Ehinger, N Ditzel, M Kassem and S Scheding. (2011). CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization. Blood 117: 5067-5077.
8. Aicher WK, HJ Buhring, ML Hart, B Rolauffs, A Badke and G Klein. (2011). Regeneration of cartilage and bone by defined subsets of mesenchymal stromal cells-potential and pitfalls. Adv Drug Deliv Rev 63:342-351.
9. Friedenstein AJ, Chailakhyan RK and U Gerasimov, V. (1987). Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet 20:263-272.
10. Chamberlain G, J Fox, B Ashton and J Middleton. (2007). Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25:2739-2749.
11. Kolf CM, E Cho and RS Tuan. (2007). Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther 9:204.
12. Buhring HJ, S Treml, F Cerabona, P de Zwart, L Kanz and M Sobiesiak. (2009). Phenotypic characterization of distinct human bone marrow-derived MSC subsets. Ann N Y Acad Sci 1176:124-134.
13. Sivasubramaniyan K, D Lehnen, R Ghazanfari, M Sobiesiak, A Harichandan, E Mortha, N Petkova, S Grimm, F Cerabona, et al. (2012). Phenotypic and functional heterogeneity of human bone marrow- and amnion-derived MSC subsets. Ann N Y Acad Sci 1266:94-106.
14. Battula VL, PM Bareiss, S Treml, S Conrad, I Albert, S Hojak, H Abele, B Schewe, L Just, T Skutella and HJ Buhring. (2007). Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. Differentiation 75:279-291.
15. Battula VL, S Treml, PM Bareiss, F Gieseke, H Roelofs, P de Zwart, I Müller, B Schewe, T Skutella, et al. (2009). Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271 and mesenchymal stem cell antigen-1 (MSCA-1). Hematologica 94:19-30.
16. Gang EJ, D Bosnakovski, CA Figueiredo, JW Visser and RCR Perlingeiro. (2007). SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood 109:1743-1751.
17. Bae S, CW Park, HK Son, HK Ju, D Paik, CJ Jeon, GY Koh, J Kim and H Kim. (2008). Fibroblast activation protein alpha identifies mesenchymal stromal cells from human bone marrow. Br J Haematol 142:827-830.
18. Sivasubramaniyan K, A Harichandan, S Schumann, M Sobiesiak, C Lengerke, A Maurer, H Kalbacher and HJ Buhring. (2013). Prospective isolation of mesenchymal stem cells from human bone marrow using novel antibodies directed against Sushi domain containing 2. Stem Cells Dev 22:1944-1954.
19. Sobiesiak M, K Sivasubramaniyan, C Hermann, C Tan, M Orgel, S Treml, F Cerabona, P de Zwart, U Ochs, et al. (2010). The mesenchymal stem cell antigen MSCA-1 is identical to tissue non-specific alkaline phosphatase. Stem Cells Dev 19:669-677.
20. Vogel W, F Grünebach, CA Messam, L Kanz, W Brugger and HJ Bühring. (2003). Heterogeneity among human bone marrow-derived mesenchymal stem cells and neural progenitor cells. Haematologica 88:126-133.
21. Buhring HJ, VL Battula, S Treml, B Schewe, L Kanz and W Vogel. (2007). Novel markers for the prospective isolation of human MSC. Ann N Y Acad Sci 1106:262-271.
22. Alexander D, F Schäfer, A Munz, B Friedrich, C Klein, J Hoffmann, HJ Bühring and S Reinert. (2009). NGFR: a new osteogenic differentiation marker in mineralizing periosteal cells. Tissue Eng 15:715.
23. Pilz G, C Ulrich, T Abruzzese, H Abele, R Schäfer, HJ Buhring and WK Aicher. (2011). Human term placenta-derived mesenchymal stromal cells are less prone to osteogenic differentiation than bone marrow-derived mesenchymal stromal cells. Stem Cells Dev 20:635-646.
24. Ulrich C, B Rolauffs, H Abele, M Bonin, K Nieselt, ML Hart and WK Aicher. (2013). Low osteogenic differentiation potential of placenta-derived mesenchymal stromal cells correlates with low expression of the transcription factors Runx2 and Twist2. Stem Cells Dev 22:2859-2872.
25. Anfosso F, N Bardin, V Frances, E Vivier, L Camoin-Jau, J Sampol and F Dignat-George. (1998). Activation of human endothelial cells via S-Endo-1 antigen (CD146) stimulates the tyrosine phosphorylation of focal adhesion kinase p125FAK. J Biol Chem 273:26852-26856.
26. Elshal MF, SS Khan, N Raghavachari, Y Takahashi, J Barb, JJ Bailey, PJ Munson, MA Solomon, RL Danner and JP McCoy, Jr. (2007). A unique population of effector memory lymphocytes identified by CD146 having a distinct immunophenotypic and genomic profile. BMC Immunol 8:29.
27. Yang H, L Zhang, SM Weakley, PH Lin, Q Yao and C Chen. (2011). Transforming growth factor-beta increases the expression of vascular smooth muscle cell markers in human multi-lineage progenitor cells. Med Sci Monit 17: BR55-BR61.
28. Espagnolle N, F Guilloton, F Deschaseaux, M Gadelorge, L Sensebe and P Bourin. (2014). CD146 expression on mesenchymal stem cells is associated with their vascular smooth muscle commitment. J Cell Mol Med 18:104-114.
29. Crisan M, M Corselli, WCW Chen and B Péault. (2012). Perivascular cells for regenerative medicine. J Cell Mol Med 16:2851-2860.
30. Zannettino ACW, S Paton, A Arthur, F Khor, S Itescu, JM Gimble and S Gronthos. (2008). Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. J Cell Physiol 214:413-421.
31. Covas DT, RA Panepucci, AM Fontes, WA Silva, Jr., MD Orellana, MC Freitas, L Neder, AR Santos, LC Peres, MC Jamur and MA Zago. (2008). Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146 + perivascular cells and fibroblasts. Exp Hematol 36:642-654.
32. Crisan M, S Yap, L Casteilla, CW Chen, M Corselli, TS Park, G Andriolo, B Sun, B Zheng, et al. (2008). A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3:301-313.
33. Russell KC, DG Phinney, MR Lacey, BL Barrilleaux, KE Meyertholen and KC O'Connor. (2010). In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment. Stem Cells 28:788-798.
34. Masuda H, SS Anwar, HJ Buhring, JR Rao and CE Gargett. (2012). A novel marker of human endometrial mesenchymal stem-like cells. Cell Transplant 21:2201-2214.
35. Flanagan K, K Fitzgerald, J Baker, K Regnstrom, S Gardai, F Bard, S Mocci, P Seto, M You, et al. (2012). Laminin- 411 is a vascular ligand for MCAM and facilitates TH17 cell entry into the CNS. PLoS One 7:e40443.
36. Bardin N, M Blot-Chabaud, N Despoix, A Kebir, K Harhouri, JP Arsanto, L Espinosa, P Perrin, S Robert, et al. (2009). CD146 and its soluble form regulate monocyte transendothelial migration. Arterioscler Thromb Vasc Biol 29:746-753.
37. Felka T, R Schäfer, P deZwart and WK Aicher. (2010). Animal serum- free differentiation of human mesenchymal stem cells. Cytotherapy 12:143-153.
38. Felka T, R Schäfer, B Schewe, K Benz and WK Aicher. (2009). Hypoxia reduces the inhibitpry effect of IL-1beta on chondrogenic differentiation of FCS-free expanded MSC. Osteoarthritis Cartilage 17:1368-1376.
39. Herzenberg LA, J Tung, WA Moore, LA Herzenberg and DR Parks. (2006). Interpreting flow cytometry data: a guide for the perplexed. Nat Immunol 7:681-685.
40. Pittenger MF, JD Mosca and KR McIntosh. (2000). Human mesenchymal stem cells: progenitor cells for cartilage, bone, fat and stroma. Curr Top Microbiol Immunol 251: 3-11.
41. Warstat K, D Meckbach, M Weis-Klemm, A Hack, G Klein, P de Zwart and WK Aicher. (2010). TGF-b enhances the integrin a2b1-mediated attachment of mesenchymal stem cells to type I collagen. Stem Cells Dev 19:645-656.
42. Johnson JP. (1999). Cell adhesion molecules in the development and progression of malignant melanoma. Cancer Metastasis Rev 18:345-357.
43. Wang Z and X Yan. (2013). CD146, a multi-functional molecule beyond adhesion. Cancer Lett 330:150-162.
44. Zhu W, Y Tan, Q Qiu, X Li, Z Huang, Y Fu and M Liang. (2013). Comparison of the properties of human CD146 + and CD146- periodontal ligament cells in response to stimulation with tumour necrosis factor alpha. Arch Oral Biol 58:1791-1803.
45. Hashemi SM, S Ghods, FD Kolodgie, K Parcham-Azad, M Keane, D Hamamdzic, R Young, MK Rippy, R Virmani, H Litt and RL Wilensky. (2008). A placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction. Eur Heart J 29:251-259.
46. Stopp S, M Bornhauser, F Ugarte, M Wobus, M Kuhn, S Brenner and S Thieme. (2013). Expression of the melanoma cell adhesion molecule in human mesenchymal stromal cells regulates proliferation, differentiation, and maintenance of hematopoietic stem and progenitor cells. Haematologica 98:505-513.
47. Hagmann S, S Frank, T Gotterbarm, T Dreher, V Eckstein and B Moradi. (2014). Fluorescence activated enrichment of CD146 + cells during expansion of human bone-marrow derived mesenchymal stromal cells augments proliferation and GAG/DNA content in chondrogenic media. BMC Musculoskelet Disord 15:322.
48. Fayazi M, M Salehnia and S Ziaei. (2014). Differentiation of human CD146-positive endometrial stem cells to adipogenic-, osteogenic-, neural progenitor-, and glial-like cells. In Vitro Cell Dev Biol Anim. [Epub ahead of print]; DOI: 10.1007/s11626-014-9842-2.
49. Cheng T, N Rodrigues, H Shen, Y-g Yang, D Dombkowski, M Sykes and DT Scadden. (2000). Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 287: 1804-1808.
50. Pietras EM, MR Warr and E Passegué. (2011). Cell cycle regulation in hematopoietic stem cells. J Cell Biol 195: 709-720.
51. Fuchs E, T Tumbar and G Guasch. (2004). Socializing with the neighbors: stem cells and their niche. Cell 116:769-778.
52. Orford KW and DT Scadden. (2008). Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation. Nat Rev Genet 9:115-128.
53. Wagner W, RE Feldmann, Jr., A Seckinger, MH Maurer, F Wein, J Blake, U Krause, A Kalenka, HF Burgers, et al. (2006). The heterogeneity of human mesenchymal stem cell preparations-evidence from simultaneous analysis of proteomes and transcriptomes. Exp Hematol 34:536-548.
54. Azouna N, F Jenhani, Z Regaya, L Berraeis, T Othman, E Ducrocq and J Domenech. (2012). Phenotypical and functional characteristics of mesenchymal stem cells from bone marrow: comparison of culture using different media supplemented with human platelet lysate or fetal bovine serum. Stem Cell Res Ther 3:6.
55. Hagmann S, B Moradi, S Frank, T Dreher, P Kammerer, W Richter and T Gotterbarm. (2013). Different culture media affect growth characteristics, surface marker distribution and chondrogenic differentiation of human bone marrow-derived mesenchymal stromal cells. BMC Musculoskeletal Disorders 14:223.
56. Battula VL, S Treml, H Abele and HJ Buhring. (2008). Prospective isolation and characterization of mesenchymal stem cells from human placenta using a frizzled-9-specific monoclonal antibody. Differentiation 76:326-336.
57. Ben Azouna N, F Jenhani, Z Regaya, L Berraeis, T Ben Othman, E Ducrocq and J Domenech. (2012). Phenotypical and functional characteristics of mesenchymal stem cells from bone marrow: comparison of culture using different media supplemented with human platelet lysate or fetal bovine serum. Stem Cell Res Ther 3:6.
58. De Bari C, F Dell'Accio, P Tylzanowski and FP Luyten. (2001). Multipotent mesenchymal stem cells from adult synovial membrane. Arthritis Rheum 44:1928-1942.
59. Zuk PA, M Zhu, H Mizuno, J Huang, JW Futrell, AJ Katz, P Benhaim, HP Lorenz and MH Hedrick. (2001). Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7:211-228.
60. Yumi F, N Hideaki, S Daisuke, H Imiko, K Toshio and T Kohichiro. (2004). Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells 22:649-658.
61. Kern S, H Eichler, J Stoeve, H Kluter and K Bieback. (2006). Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24:1294-1301.
62. Kanematsu D, T Shofuda, A Yamamoto, C Ban, T Ueda, M Yamasaki and Y Kanemura. (2011). Isolation and cellular properties of mesenchymal cells derived from the decidua of human term placenta. Differentiation 82:77-88.
63. Muraglia A, R Cancedda and R Quarto. (2000). Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 113:1161-1166.
64. Mitchell JB, K McIntosh, S Zvonic, S Garrett, ZE Floyd, A Kloster, Y Di Halvorsen, RW Storms, B Goh, et al. (2006). Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells 24:376-385.